vs

Side-by-side financial comparison of FONAR CORP (FONR) and FiscalNote Holdings, Inc. (NOTE). Click either name above to swap in a different company.

FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $22.2M, roughly 1.2× FiscalNote Holdings, Inc.). On growth, FONAR CORP posted the faster year-over-year revenue change (2.4% vs -24.7%). FONAR CORP produced more free cash flow last quarter ($-227.0K vs $-1.9M). Over the past eight quarters, FONAR CORP's revenue compounded faster (-0.3% CAGR vs -16.8%).

FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.

FiscalNote Holdings, Inc., or commonly FiscalNote, is a publicly traded software, data, and media company headquartered in Washington, D.C. The company was founded by Timothy Hwang, Gerald Yao, and Jonathan Chen in 2013. FiscalNote provides software tools, platforms, data services, and news through the FiscalNote Government Relationship Management (GRM) service, its core product. The company also uses an artificial intelligence platform to analyze proposed U.S. legislation based on key phrase...

FONR vs NOTE — Head-to-Head

Bigger by revenue
FONR
FONR
1.2× larger
FONR
$25.5M
$22.2M
NOTE
Growing faster (revenue YoY)
FONR
FONR
+27.0% gap
FONR
2.4%
-24.7%
NOTE
More free cash flow
FONR
FONR
$1.7M more FCF
FONR
$-227.0K
$-1.9M
NOTE
Faster 2-yr revenue CAGR
FONR
FONR
Annualised
FONR
-0.3%
-16.8%
NOTE

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
FONR
FONR
NOTE
NOTE
Revenue
$25.5M
$22.2M
Net Profit
$2.1M
Gross Margin
Operating Margin
13.5%
-83.7%
Net Margin
8.0%
Revenue YoY
2.4%
-24.7%
Net Profit YoY
4.7%
EPS (diluted)
$-2.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FONR
FONR
NOTE
NOTE
Q4 25
$25.5M
$22.2M
Q3 25
$26.0M
$22.4M
Q2 25
$27.3M
$23.3M
Q1 25
$27.2M
$27.5M
Q4 24
$24.9M
$29.5M
Q3 24
$25.0M
$29.4M
Q2 24
$25.9M
$29.2M
Q1 24
$25.7M
$32.1M
Net Profit
FONR
FONR
NOTE
NOTE
Q4 25
$2.1M
Q3 25
$2.3M
$-24.9M
Q2 25
$729.3K
$-13.3M
Q1 25
$2.5M
$-4.3M
Q4 24
$2.0M
Q3 24
$3.1M
$-14.9M
Q2 24
$830.4K
$-12.8M
Q1 24
$1.9M
$50.6M
Operating Margin
FONR
FONR
NOTE
NOTE
Q4 25
13.5%
-83.7%
Q3 25
14.1%
-43.4%
Q2 25
5.3%
-31.9%
Q1 25
15.2%
-50.0%
Q4 24
11.9%
-19.4%
Q3 24
21.0%
-23.1%
Q2 24
7.4%
-27.2%
Q1 24
16.8%
-35.6%
Net Margin
FONR
FONR
NOTE
NOTE
Q4 25
8.0%
Q3 25
8.7%
-110.8%
Q2 25
2.7%
-57.0%
Q1 25
9.2%
-15.4%
Q4 24
7.9%
Q3 24
12.6%
-50.7%
Q2 24
3.2%
-43.6%
Q1 24
7.3%
157.6%
EPS (diluted)
FONR
FONR
NOTE
NOTE
Q4 25
$-2.81
Q3 25
$-1.73
Q2 25
$-0.08
Q1 25
$-0.03
Q4 24
$1.88
Q3 24
$-1.33
Q2 24
$-0.09
Q1 24
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FONR
FONR
NOTE
NOTE
Cash + ST InvestmentsLiquidity on hand
$121.0K
$26.3M
Total DebtLower is stronger
$128.4M
Stockholders' EquityBook value
$176.9M
$62.0M
Total Assets
$217.2M
$255.1M
Debt / EquityLower = less leverage
2.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FONR
FONR
NOTE
NOTE
Q4 25
$121.0K
$26.3M
Q3 25
$122.0K
$31.2M
Q2 25
$56.5M
$38.5M
Q1 25
$123.0K
$46.3M
Q4 24
$121.0K
$34.6M
Q3 24
$136.0K
$32.7M
Q2 24
$56.5M
$37.7M
Q1 24
$134.0K
$43.6M
Total Debt
FONR
FONR
NOTE
NOTE
Q4 25
$128.4M
Q3 25
$131.5M
Q2 25
$116.7M
Q1 25
$118.0M
Q4 24
$147.1M
Q3 24
$152.2M
Q2 24
$66.9K
$145.9M
Q1 24
$153.0M
Stockholders' Equity
FONR
FONR
NOTE
NOTE
Q4 25
$176.9M
$62.0M
Q3 25
$174.9M
$75.5M
Q2 25
$172.6M
$95.1M
Q1 25
$171.9M
$98.7M
Q4 24
$169.8M
$97.8M
Q3 24
$168.7M
$98.5M
Q2 24
$166.0M
$106.9M
Q1 24
$165.8M
$106.1M
Total Assets
FONR
FONR
NOTE
NOTE
Q4 25
$217.2M
$255.1M
Q3 25
$218.4M
$273.9M
Q2 25
$216.9M
$288.3M
Q1 25
$214.9M
$299.7M
Q4 24
$208.0M
$326.2M
Q3 24
$212.3M
$337.9M
Q2 24
$214.2M
$346.3M
Q1 24
$209.6M
$357.8M
Debt / Equity
FONR
FONR
NOTE
NOTE
Q4 25
2.07×
Q3 25
1.74×
Q2 25
1.23×
Q1 25
1.20×
Q4 24
1.50×
Q3 24
1.54×
Q2 24
0.00×
1.36×
Q1 24
1.44×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FONR
FONR
NOTE
NOTE
Operating Cash FlowLast quarter
$171.0K
$-279.0K
Free Cash FlowOCF − Capex
$-227.0K
$-1.9M
FCF MarginFCF / Revenue
-0.9%
-8.7%
Capex IntensityCapex / Revenue
1.6%
7.4%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters
$5.7M
$-18.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FONR
FONR
NOTE
NOTE
Q4 25
$171.0K
$-279.0K
Q3 25
$1.7M
$-8.3M
Q2 25
$4.2M
$-6.2M
Q1 25
$3.1M
$3.3M
Q4 24
$2.2M
$-1.3M
Q3 24
$1.7M
$-3.0M
Q2 24
$4.6M
$-3.7M
Q1 24
$2.8M
$2.7M
Free Cash Flow
FONR
FONR
NOTE
NOTE
Q4 25
$-227.0K
$-1.9M
Q3 25
$-177.0K
$-10.4M
Q2 25
$3.6M
$-7.7M
Q1 25
$2.6M
$1.3M
Q4 24
$1.5M
$-3.4M
Q3 24
$-148.0K
$-5.4M
Q2 24
$4.2M
$-6.5M
Q1 24
$2.6M
$1.0M
FCF Margin
FONR
FONR
NOTE
NOTE
Q4 25
-0.9%
-8.7%
Q3 25
-0.7%
-46.2%
Q2 25
13.1%
-33.0%
Q1 25
9.4%
4.7%
Q4 24
6.0%
-11.4%
Q3 24
-0.6%
-18.4%
Q2 24
16.1%
-22.1%
Q1 24
10.2%
3.3%
Capex Intensity
FONR
FONR
NOTE
NOTE
Q4 25
1.6%
7.4%
Q3 25
7.2%
9.3%
Q2 25
2.4%
6.4%
Q1 25
2.2%
7.2%
Q4 24
3.0%
6.8%
Q3 24
7.2%
8.3%
Q2 24
1.6%
9.4%
Q1 24
0.7%
5.3%
Cash Conversion
FONR
FONR
NOTE
NOTE
Q4 25
0.08×
Q3 25
0.75×
Q2 25
5.79×
Q1 25
1.26×
Q4 24
1.14×
Q3 24
0.53×
Q2 24
5.54×
Q1 24
1.50×
0.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FONR
FONR

Managementof Diagnostic Imaging Centers$23.2M91%
Manufacturingand Servicingof Medical Equipment$2.4M9%

NOTE
NOTE

Subscription$21.2M95%
Advisory Advertising And Other$1.0M5%

Related Comparisons